Breaking News Instant updates and real-time market news.

EMS

Emergency Medical

, CLCD

CoLucid Pharmaceuticals

$36.26

-0.7 (-1.89%)

08:30
10/07/16
10/07
08:30
10/07/16
08:30

Five new option listings and four option delistings on October 7th

New option listings for October 7th include FTSE Emerging Index Settlement Value (.EMS), CoLucid Pharmaceuticals (CLCD), Donnelley Financial Solutions Inc (DFIN), LSC Communications Inc (LKSD), and Silver Run Acquisition Corp (SRAQ). Option delistings effective October 7th include FTSE Emerging Index (.FTEM), Hutchinson Technolgy Incorporated (HTCH), Parkway Properties Inc (PKY), and Warren Resources Inc (WRESQ).

EMS

Emergency Medical

CLCD

CoLucid Pharmaceuticals

$36.26

-0.7 (-1.89%)

DFIN

Donnelley Financial Solutions

$21.87

0.02 (0.09%)

LKSD

LSC Communications

$26.89

-0.19 (-0.70%)

HTCH

Hutchinson Technology

PKY

Parkway

  • 10

    Nov

EMS Emergency Medical

CLCD CoLucid Pharmaceuticals
$36.26

-0.7 (-1.89%)

09/06/16
LTCO
09/06/16
NO CHANGE
Target $52
LTCO
Buy
CoLucid price target raised to $52 from $23 at Ladenburg
Ladenburg raised CoLucid's price target to $52 from $23 following achievement of both primary and key secondary endpoints in the SAMURAI Phase III pivotal trial of Lasmiditan in migraine.
09/06/16
WBLR
09/06/16
NO CHANGE
Target $30
WBLR
Outperform
CoLucid price target raised to $30 from $22 at William Blair
William Blair analyst Tim Lugo raised his price target for CoLucid Pharmaceuticals to $30 after the company announced positive results from its first pivotal Phase III trial with lead candidate lasmiditan for the treatment of acute migraine. The data "remove a major clinical overhang" for the shares since the trial endpoints were established in line with the FDA's draft guidance for acute migraine therapies, Lugo tells investors in a research note. He keeps an Outperform rating on the shares. CoLucid is up 78% to $19.00 in pre-market trading.
09/15/16
PIPR
09/15/16
NO CHANGE
Target $36
PIPR
Overweight
CoLucid price target raised to $36 from $21 at Piper Jaffray
Piper Jaffray analyst Charles Duncan raised his price target for CoLucid Pharmaceuticals to $36 saying the positive Phase III results from lasmiditan de-risk further development of the "novel mechanism" in acute migraine. The analyst reiterates an Overweight rating on the shares.
09/19/16
LTCO
09/19/16
NO CHANGE
Target $57
LTCO
Buy
CoLucid could have takeout potential following lasmiditan data, says Ladenburg
After CoLucid presented additional detail on its Phase 3 pivotal trial evaluating lasmiditan, the "SAMURAI" study, Ladenburg Thalmann analyst Robert Hazlett said the additional details support the drug's efficacy in the treatment of acute migraine. Hazlett now includes the potential for a takeover in his valuation of the stock, explaining that he values CoLucid at $45.71 per share as a stand-alone entity and values it at $68.13 per share using a takeover scenario, arriving at a raised $57 price target, up from his prior target of $52. Hazlett maintains a Buy rating on CoLucid shares, which are up about 4% to $29.19 in pre-market trading.
DFIN Donnelley Financial Solutions
$21.87

0.02 (0.09%)

LKSD LSC Communications
$26.89

-0.19 (-0.70%)

HTCH Hutchinson Technology

PKY Parkway

08/17/16
BARD
08/17/16
DOWNGRADE
Target $18
BARD
Neutral
Parkway Properties downgraded to Neutral at Baird
As reported previously, Baird analyst David Rodgers downgraded Parkway Properties to Neutral from Outperform as he expects market rates to decline and the less attractiveness of the companies assets relative to peers. Rodgers lowered his price target to $18 from $19 on Parkway Properties shares.
08/31/16
RAJA
08/31/16
DOWNGRADE
RAJA
Market Perform
Parkway Properties downgraded to Market Perform at Raymond James
Raymond James analyst William Crow downgraded Parkway Properties (PKY) to Market Perform from Outperform citing the upcoming merger with Cousins Properties (CUZ).
09/28/16
STFL
09/28/16
DOWNGRADE
STFL
Sell
Parkway Properties downgraded to Sell from Hold at Stifel
09/29/16
STFL
09/29/16
DOWNGRADE
STFL
Sell
Parkway Properties downgraded based on valuation at Stifel
As noted earlier, Stifel downgraded Parkway Properties (PKW) to Sell from Hold. Analyst John Guinee downgraded the stock based on valuation. .Additionally, he notes that Parkway and Cousins (CUZ) have agreed to merge and then spin off Houston-based assets. The analyst thinks that investors will lack information about various aspects of the combined company in the wake of the spin off announcement. Parkway target to $15.50 from $18.50.

TODAY'S FREE FLY STORIES

OCLR

Oclaro

$9.72

-1.25 (-11.39%)

20:45
02/22/17
02/22
20:45
02/22/17
20:45
Conference/Events
Oclaro management to meet with Jefferies »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

GMS

GMS Inc.

$29.79

-0.52 (-1.72%)

20:32
02/22/17
02/22
20:32
02/22/17
20:32
Syndicate
GMS Inc. 6.95M share Secondary priced at $29.25 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

APA

Apache

$54.91

-0.98 (-1.75%)

, HRL

Hormel Foods

$37.30

-0.3 (-0.80%)

20:25
02/22/17
02/22
20:25
02/22/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

APA

Apache

$54.91

-0.98 (-1.75%)

HRL

Hormel Foods

$37.30

-0.3 (-0.80%)

KSS

Kohl's

PF

Pinnacle Foods

$54.63

-0.61 (-1.10%)

CHK

Chesapeake

$5.92

-0.16 (-2.63%)

CNK

Cinemark

$43.39

0.51 (1.19%)

AMCX

AMC Networks

$57.50

-0.19 (-0.33%)

W

Wayfair

$41.26

1 (2.48%)

SFM

Sprouts Farmers Markets

$19.00

-0.32 (-1.66%)

TREE

LendingTree

$112.15

-1.45 (-1.28%)

TXMD

TherapeuticsMD

$5.67

0.08 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 16

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 07

    May

  • 11

    May

FIT

Fitbit

$5.88

-0.16 (-2.65%)

20:14
02/22/17
02/22
20:14
02/22/17
20:14
Hot Stocks
Fitbit CEO says early adopter segment saturated, says exploring new form factors »

Speaking during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

SQ

Square

$15.04

0.41 (2.80%)

19:57
02/22/17
02/22
19:57
02/22/17
19:57
Upgrade
Square rating change  »

Square upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

FIT

Fitbit

$5.88

-0.16 (-2.65%)

19:50
02/22/17
02/22
19:50
02/22/17
19:50
Hot Stocks
Fitbit says paid $23M for Pebble assets »

Fitbit disclosed in its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

SBUX

Starbucks

$57.57

0.03 (0.05%)

19:34
02/22/17
02/22
19:34
02/22/17
19:34
Hot Stocks
Market researcher: Starbucks consumer perception dips after refugee hiring news »

Market researcher YouGov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

LB

Labarge

$58.13

0.43 (0.75%)

19:33
02/22/17
02/22
19:33
02/22/17
19:33
Hot Stocks
L Brands sees Q1 comps down high-single to low-double digits »

Sees Q1 Go-Forwards comps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LB

Labarge

$58.13

0.43 (0.75%)

19:32
02/22/17
02/22
19:32
02/22/17
19:32
Hot Stocks
L Brands sees FY17 comps down low-single digits »

Sees FY17 Go-Forward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

F

Ford

$12.67

-0.02 (-0.16%)

19:30
02/22/17
02/22
19:30
02/22/17
19:30
Conference/Events
Ford to host sales conference call »

Ford U.S. Sales Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

GTLS

Chart Industries

$38.51

-1.21 (-3.05%)

19:27
02/22/17
02/22
19:27
02/22/17
19:27
Hot Stocks
Chart Industries CEO Samuel Thomas named executive chairman »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$273.51

-3.88 (-1.40%)

19:24
02/22/17
02/22
19:24
02/22/17
19:24
Periodicals
SolarCity leased with risky homeowners, has ties to foreclosure cases, NYT says »

In "dozens of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

PRU

Prudential

$110.50

-0.72 (-0.65%)

, WFC

Wells Fargo

$58.36

0.11 (0.19%)

19:16
02/22/17
02/22
19:16
02/22/17
19:16
Hot Stocks
Prudential says could seek compensation from Wells Fargo over MyTerm products »

Prudential (PRU) stated…

PRU

Prudential

$110.50

-0.72 (-0.65%)

WFC

Wells Fargo

$58.36

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 13

    Apr

  • 06

    Jun

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

PSA

Public Storage

$226.24

-1.49 (-0.65%)

19:15
02/22/17
02/22
19:15
02/22/17
19:15
Earnings
Public Storage reports Q4 core FFO $2.65, consensus $1.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CS

Credit Suisse

$15.35

-0.13 (-0.84%)

19:10
02/22/17
02/22
19:10
02/22/17
19:10
Periodicals
Credit Suisse probed for potentially aiding tax evasion, WSJ says »

Less than three years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

LZB

La-Z-Boy

$28.40

-1.05 (-3.57%)

19:09
02/22/17
02/22
19:09
02/22/17
19:09
Downgrade
La-Z-Boy rating change  »

La-Z-Boy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CLD

Cloud Peak

$5.68

-0.19 (-3.24%)

19:06
02/22/17
02/22
19:06
02/22/17
19:06
Syndicate
Cloud Peak 13.5M share Spot Secondary priced at $5.10 »

Credit Suisse, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SNAP

Snap Inc

18:47
02/22/17
02/22
18:47
02/22/17
18:47
Periodicals
Snap Inc nears $200M ad deal, NY Post says »

Snap Inc is close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

SBLK

Star Bulk Carriers

$9.59

0.29 (3.12%)

18:40
02/22/17
02/22
18:40
02/22/17
18:40
Earnings
Star Bulk Carriers reports Q4 EPS (29c), consensus (28c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

C

Citi

$60.62

0.07 (0.12%)

18:35
02/22/17
02/22
18:35
02/22/17
18:35
Periodicals
Citi forms regulatory affairs team in D.C., Bloomberg says »

Citi is forming a global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:34
02/22/17
02/22
18:34
02/22/17
18:34
Earnings
PRA Health sees FY17 EPS $3.08-$3.18, consensus $2.96 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

, ATH

Athene Holding

$51.45

0.38 (0.74%)

18:32
02/22/17
02/22
18:32
02/22/17
18:32
Periodicals
Fidelity & Guaranty Life revives sale process, Insurance Insider says »

Fidelity & Guaranty…

FGL

Fidelity & Guaranty Life

$26.30

-0.1 (-0.38%)

ATH

Athene Holding

$51.45

0.38 (0.74%)

APO

Apollo Global

$22.25

0.05 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

PRAH

PRA Health

$59.98

-0.71 (-1.17%)

18:31
02/22/17
02/22
18:31
02/22/17
18:31
Earnings
PRA Health sees Q1 EPS 57c-62c, consensus 67c »

Sees Q1 service revenues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

NBR

Nabors Industries

$15.44

0.01 (0.06%)

18:30
02/22/17
02/22
18:30
02/22/17
18:30
Earnings
Nabors Industries reports Q4 EPS ($1.17) with items »

Q4 EPS includes 87c in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

AXGN

AxoGen

$10.50

-0.1 (-0.94%)

18:28
02/22/17
02/22
18:28
02/22/17
18:28
Earnings
AxoGen reiterates FY17 revenue growth view of at least 40% »

Management reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

  • 21

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.